ok...... i know there's no public request for it but........this certainly needs to be said!
these guys have a huge problem. i can't see them taking SBC103 into the clinic with 50% substrate clearance vs biomarin's 80%. they need to backfill their marketcap as soon as they can with something as significant as possible. what's nice about geva is that they are young and still in the process of defining who they are. i don't think the Baker brothers are all that concerned about how they "define themselves" either. i'm thinking they can define themselves with a cns pipeline quite nicely.
good setup for either a $500 stock or a $0.50 stock and its all going to depend on how they play it!
as for me, i'm a winner either way cause someone will go after the utility that makes the cns pipeline a reality!
these are my thoughts, not yours, i'm............................
#toindwbmahbnDRJ!